ALLYN T. LONDREGAN,DAVID A. PRICE,ESTHER CHENG YIN LEE,JANA POLIVKOVA,KENTARO FUTATSUGI,KIM HUARD,MARKUS BOEHM,MATTHEW S. DOWLING,QIFANG LI,SHAWN CABRAL
申请号：
BR112019001976
公开号：
BR112019001976A2
申请日:
2017.08.09
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to novel pharmaceutical compounds, pharmaceutical compositions containing these compounds, and their use to inhibit the activity of diacylglycerol acyltransferase 2 (dgat2).a presente invenção refere-se a novos compostos farmacêuticos, composições farmacêuticas contendo estes compostos, e sua utilização para inibir a atividade da diacilglicerol aciltransferase 2 (dgat2).
